Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Citi
Accenture
QuintilesIMS
McKinsey
Fuji
AstraZeneca
Cerilliant

Generated: September 19, 2018

DrugPatentWatch Database Preview

CEFUROXIME AXETIL Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Cefuroxime Axetil patents expire, and when can generic versions of Cefuroxime Axetil launch?

Cefuroxime Axetil is a drug marketed by Sun Pharm Inds Ltd, Alkem Labs Ltd, Ani Pharms Inc, Apotex, Aurobindo Pharma Ltd, Fosun Pharma, Lupin, Orchid Hlthcare, Ranbaxy Labs Ltd, and Wockhardt. and is included in eleven NDAs.

The generic ingredient in CEFUROXIME AXETIL is cefuroxime axetil. There are sixty-one drug master file entries for this compound. Twenty-eight suppliers are listed for this compound. Additional details are available on the cefuroxime axetil profile page.

Drug patent expirations by year for CEFUROXIME AXETIL
Pharmacology for CEFUROXIME AXETIL
Synonyms for CEFUROXIME AXETIL
(6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furanyl)-2-methoxyimino-1-oxoethyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid 1-acetyloxyethyl ester
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2E)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-(Acetyloxy)ethyl Ester
(6R,7R)-3-[[(Aminocarbonyl)oxy]methyl]-7-[[(2Z)-2-(2-furanyl)-2-(methoxyimino)acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 1-(Acetyloxy)ethyl Ester
(E)-Cefuroxime Axetil
(RS)-1-Hydroxyethyl (6R,7R)-7-(2-(2-furyl)glyoxylamido)-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylate, 7(sup 2)-(Z)-(O-methyloxime), 1-acetate 3-carbamate
1-(acetyloxy)ethyl (6R,7R)-3-{[(aminocarbonyl)oxy]methyl}-7-({(2E)-2-furan-2-yl-2-[(methyloxy)imino]acetyl}amino)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-(acetyloxy)ethyl(6r,7r)-3-[(carbamoyloxy)methyl]-7-{[furan-2-yl(methoxyimino)acetyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-[(6R,7R)-3-[(CARBAMOYLOXY)METHYL]-7-[(2Z)-2-(FURAN-2-YL)-2-(METHOXYIMINO)ACETAMIDO]-8-OXO-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBONYLOXY]ETHYL ACETATE
1-acetoxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(2-furyl)-2-methoxyimino-acetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-Acetoxyethyl (6R,7R)-3-carbamoyloxymethyl-7-[(Z)-2-(fur-2-yl)-2-methoxyiminoacetamido]ceph-3-em-4-carboxylate
1-acetyloxyethyl (6R,7R)-3-(aminocarbonyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyimino-ethanoyl]amino]-8-oxidanylidene-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2E)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl (6R,7R)-3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl 3-(carbamoyloxymethyl)-7-[[(2Z)-2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1-acetyloxyethyl 3-(carbamoyloxymethyl)-7-[[2-(furan-2-yl)-2-methoxyiminoacetyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 3-(((aminocarbonyl)oxy)methyl)-7-((2-furanyl(methoxyimino)acetyl)amino)-8-oxo-, 1-(acetyloxy)ethyl ester, (6R-(6alpha,7beta(Z)))-
544C076
64544-07-6
97232-96-7
A834806
AB00053386_02
AC1L2I23
AC1MP5LV
AC1NSF88
AC1NXLB3
AC1O426M
AC1Q6LOH
AKOS015896220
AKOS015966892
AKOS030242591
Altacef
AN-38773
anti-Cefloxime axetil
API0001920
AS-14135
AT-20730
Bioracef
BRN 6854419
C08107
C20H22N4O10S
CC0151
CCG-213274
CCG-221241
CCI 1564
CCI 15641
CCI-15641
Cefaks
Cefazine
Ceftin
Cefuroximaxetil
Cefuroxime 1-acetoxyethyl ester
Cefuroxime axetil (JP17/USP/INN)
Cefuroxime axetil [USAN:BAN:JAN]
Cefuroxime axetil [USAN:USP:BAN:JAN]
Cefuroxime Axetil EP Impurity B
Cefuroxime axetil, (E)-
Cefuroxime Axetil, European Pharmacopoeia (EP) Reference Standard
Cefuroxime Axetil, mixture of isomers, analytical standard
Cefuroxime Axetil, United States Pharmacopeia (USP) Reference Standard
Celocid
Cepazine
Cethixim
Cetoxil
CHEBI:3516
CHEMBL1095930
Coliofossim
CTK8F8544
CXM-AX
D00914
DivK1c_006829
DRG-0157
DTXSID0022775
DTXSID20242788
Elobact
Forcef
Furoxime
HE070737
HE372488
HMS2093A20
HSDB 8150
I06-1564
K039
Kalcef
KBio1_001773
KEJCWVGMRLCZQQ-YJBYXUATSA-N
LS-149935
Maxitil
Medoxm
MolPort-003-666-792
MolPort-005-935-571
Nivador
NSC-758677
NSC758677
Pharmakon1600-01504175
SCHEMBL379336
SCHEMBL41099
SCHEMBL6859269
SCHEMBL721709
Sharox-500
SN 407
SN-407
SpecPlus_000733
SR-05000001889
SR-05000001889-1
ST51053128
VA10549
Zinat
Zinnat
Zoref

US Patents and Regulatory Information for CEFUROXIME AXETIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sun Pharm Inds Ltd CEFUROXIME AXETIL cefuroxime axetil FOR SUSPENSION;ORAL 065323-001 Feb 5, 2008 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Orchid Hlthcare CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065359-003 Feb 15, 2008 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharm Inds Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065118-003 Apr 25, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Apotex CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065069-001 Oct 2, 2002 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Alkem Labs Ltd CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065496-002 Jun 7, 2010 AB RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fosun Pharma CEFUROXIME AXETIL cefuroxime axetil TABLET;ORAL 065126-001 Oct 28, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Boehringer Ingelheim
Citi
Accenture
QuintilesIMS
McKinsey
Fuji
AstraZeneca
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.